ScienceDex / Researcher record
Vanveldhuisen, Paul
- The Emmes Company, LLC (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Sustained Excellence
- Top 5% Funded
- Long-Funded
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2007 | $2,588,547 | 1 | #1,741 |
| 2011 | $4,011,144 | 1 | #952 |
| 2012 | $3,956,081 | 1 | #928 |
| 2013 | $3,368,894 | 1 | #1,144 |
| 2014 | $3,378,726 | 1 | #1,241 |
| 2015 | $3,499,899 | 1 | #1,152 |
| 2016 | $3,582,979 | 1 | #1,042 |
| 2017 | $3,733,019 | 1 | #895 |
| 2018 | $3,219,557 | 1 | #1,243 |
| 2019 | $14,197,674 | 10 | #104 |
| 2021 | $9,597,034 | 9 | #256 |
| 2022 | $2,101,082 | 4 | #3,346 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20071 record
- FY20111 record
- FY20121 record
- FY20131 record
- FY20141 record
- FY20151 record
- FY20161 record
- FY20171 record
- FY20181 record
- FY201910 records
- FY2021 · selected9 records
- FY20224 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Vanveldhuisen, Paul as a PI. Multi-PI records show the full award amount for context.
- 75N95019D00013-0-759502100005-1N01Contact PIDSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/1/2021-8/31/2022. N01DA-19-2250. TASK ORDER 75N95021F00005 (TO2$2.4Maward amount
- 75N95019D00013-0-759502100007-1N01Contact PILONGITUDINAL FOLLOW-UP OF INDIVIDUALS WITH OPIOID USE DISORDER (LFU-OUD). 09/01/2021 - 08/31/2026. N01DA-19-2250. TASK ORDER 75N95021F00007 (TO26).$1.8Maward amount
- 75N95019D00013-0-759502100004-1N01Contact PIRandomized, double-blind, placebo-controlled trial of monthly injectable buprenorphine for methamphetamine use disorder (MURB) (CTN-0110)$1.4Maward amount
- 75N95019D00013-0-759502100003-1N01Contact PIRandomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CTN-0109)$1.2Maward amount
- 75N95019D00013-0-759502100001-1N01Contact PINIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2021 - 02/28/2022. N01DA-19-2250. TASK ORDER 75N95021F00001 (TO$1.1Maward amount
- 75N95019D00013-0-759502100006-1N01Contact PIPHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0116). 09/01/2021 - 03/01/2024. N01DA-19-2250. TASK ORDER 75N95021F00$686.8Kaward amount
- 75N95019D00013-P00002-759502000001-1N01Contact PINIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2020 - 02/28/2021. N01DA-19-2250. TASK ORDER 75N95020F00001 (TO$549.3Kaward amount
- 75N95019D00013-P00002-759501900097-1N01Contact PISUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). DSC5 CONTRACT. 09/20/2019 - 11/16/2020. N01DA-19-2250.$245.2Kaward amount
- 75N95019D00013-P00001-759502000008-1N01Contact PIDSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/21/2020-9/20/2021. N01DA-19-2250. TASK ORDER 75N95020F00008 (TO$183.1Kaward amount
Award organization
Organizations that administered FY2021 awards listing Vanveldhuisen, Paul as a PI.
FY2021 award administered by The Emmes Company, LLC (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardThe Emmes Company, LLC
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #1741
- 2007Entered Top 25% NationallyRanked #1741
- 2007Entered Top 10% NationallyRanked #1741
- 2011$5M Cumulative Funding
- 2011Entered Top 5% NationallyRanked #952
- 2012$10M Cumulative Funding
- 2017$25M Cumulative Funding
- 2019Entered Top 1% NationallyRanked #104
- 2021$50M Cumulative Funding